CN1282337A - 具有整联蛋白抑制剂特性的环肽衍生物 - Google Patents

具有整联蛋白抑制剂特性的环肽衍生物 Download PDF

Info

Publication number
CN1282337A
CN1282337A CN98812195A CN98812195A CN1282337A CN 1282337 A CN1282337 A CN 1282337A CN 98812195 A CN98812195 A CN 98812195A CN 98812195 A CN98812195 A CN 98812195A CN 1282337 A CN1282337 A CN 1282337A
Authority
CN
China
Prior art keywords
gly
asp
phe
arg
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN98812195A
Other languages
English (en)
Chinese (zh)
Inventor
J·梅尔
B·尼斯
D·芬辛格
A·乔恩吉克
H·凯斯勒
M·肯特莱纳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of CN1282337A publication Critical patent/CN1282337A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/10—Process efficiency
CN98812195A 1997-12-16 1998-12-09 具有整联蛋白抑制剂特性的环肽衍生物 Pending CN1282337A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19755800A DE19755800A1 (de) 1997-12-16 1997-12-16 Cyclopeptidderivate
DE19755800.3 1997-12-16

Publications (1)

Publication Number Publication Date
CN1282337A true CN1282337A (zh) 2001-01-31

Family

ID=7852041

Family Applications (1)

Application Number Title Priority Date Filing Date
CN98812195A Pending CN1282337A (zh) 1997-12-16 1998-12-09 具有整联蛋白抑制剂特性的环肽衍生物

Country Status (14)

Country Link
US (2) US6610826B1 (de)
EP (1) EP1037906B1 (de)
JP (1) JP3844655B2 (de)
KR (1) KR20010033103A (de)
CN (1) CN1282337A (de)
AT (1) ATE289320T1 (de)
AU (1) AU735386B2 (de)
CA (1) CA2315532C (de)
DE (2) DE19755800A1 (de)
ES (1) ES2237857T3 (de)
HU (1) HUP0004511A3 (de)
PL (1) PL340502A1 (de)
WO (1) WO1999031126A1 (de)
ZA (1) ZA9811462B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7815900B1 (en) 2000-07-11 2010-10-19 L'ORéAL S.A. Use of C3-C5 monosaccharides to protect keratinous fibers
DE10040105A1 (de) * 2000-08-17 2002-02-28 Merck Patent Gmbh Peptid- und Peptidmimetika-Derivate mit Integrin-Inhibitor-Eigenschaften
DE10040103A1 (de) * 2000-08-17 2002-02-28 Merck Patent Gmbh Peptid- und Peptidmimetika-Derivate mit Integrin-Inhibitor-Eigenschaften II
AU2001221607A1 (en) 2000-11-20 2002-05-27 Ecole Polytechnique Federale De Lausanne (Epfl) Endosseous implant
DE10325049A1 (de) * 2003-06-02 2004-12-23 Merck Patent Gmbh Peptid- und Peptidmimetika-Derivate mit Integrin-Inhibitor-Eigenschaften III
US7528106B2 (en) 2004-06-04 2009-05-05 The Scripps Research Institute Compositions and methods for treatment of neovascular diseases
AU2006262329B2 (en) * 2005-06-22 2011-04-07 Asterias Biotherapeutics, Inc. Differentiation of primate pluripotent stem cells to cardiomyocyte-lineage cells
KR101635750B1 (ko) * 2008-01-30 2016-07-04 아스테리아스 바이오세라퓨틱스, 인크. 줄기 세포 유래 올리고덴드로사이트 전구 세포를 배양하기 위한 합성 표면
SG188098A1 (en) 2008-01-30 2013-03-28 Geron Corp Synthetic surfaces for culturing stem cell derived cardiomyocytes
WO2009124754A1 (en) * 2008-04-08 2009-10-15 Merck Patent Gmbh Compositions containing cyclic peptides and methods of use
US20110183418A1 (en) * 2009-07-29 2011-07-28 Arthur Winston Martin Peptide-Polymer Cell Culture Articles and Methods of Making

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19538741A1 (de) * 1995-10-18 1997-04-24 Merck Patent Gmbh Cyclopeptidderivate
EP0844252A3 (de) * 1996-11-15 1998-07-08 Remacle, José Zyklische Peptide mit einer zur anschliessenden chemischen Kupplung entworfenen Zweiggruppe und Verfahren zu deren Herstellung
DE19725368A1 (de) * 1997-06-16 1998-12-17 Merck Patent Gmbh Cyclische Adhäsionsinhibitoren und deren Verwendung für bildgebende Verfahren

Also Published As

Publication number Publication date
EP1037906B1 (de) 2005-02-16
JP2002508392A (ja) 2002-03-19
DE19755800A1 (de) 1999-06-17
ATE289320T1 (de) 2005-03-15
US20020198142A1 (en) 2002-12-26
ES2237857T3 (es) 2005-08-01
PL340502A1 (en) 2001-02-12
CA2315532C (en) 2008-02-12
JP3844655B2 (ja) 2006-11-15
US6610826B1 (en) 2003-08-26
KR20010033103A (ko) 2001-04-25
US6995238B2 (en) 2006-02-07
CA2315532A1 (en) 1999-06-24
DE59812581D1 (de) 2005-03-24
HUP0004511A3 (en) 2001-12-28
ZA9811462B (en) 1999-06-15
HUP0004511A2 (hu) 2001-06-28
EP1037906A1 (de) 2000-09-27
WO1999031126A1 (de) 1999-06-24
AU2268999A (en) 1999-07-05
AU735386B2 (en) 2001-07-05

Similar Documents

Publication Publication Date Title
CN1203090C (zh) 环化粘合抑制剂
CN1250566C (zh) 化学修饰的多肽
CN86101850A (zh) N，n′-二烷基胍基二肽的制造方法与用途
CN1147260A (zh) 神经激肽(快速激肽)拮抗剂
CN1198841C (zh) 制备环状血管活性肽的方法
CN1041950A (zh) 新型肽酶抑制剂
CN1082027A (zh) 异羟肟酸衍生物
CN1099760A (zh) 环状粘合抑制剂
CN1085205C (zh) 双环芳香氨基酸
CN1050198A (zh) 新的肽酶和异构酶抑制剂
CN1114961A (zh) 细胞粘连肽抑制剂
CN1042918A (zh) 具有缓激肽拮抗剂作用的肽类
CN1209437A (zh) 获得具有正确键合的胱氨酸键的胰岛素前体的改进的方法
CN1098409A (zh) α-哌嗪酮及其应用
CN1282337A (zh) 具有整联蛋白抑制剂特性的环肽衍生物
CN1829738A (zh) 新型胰岛素衍生物
CN1278790A (zh) 化合物
CN1150189C (zh) 用作整联蛋白抑制剂的苯并吡喃酮和苯并二氢吡喃酮衍生物
CN1204889C (zh) 粘附受体拮抗剂
CN1099040A (zh) 线性粘合抑制剂
CN1107857A (zh) 环状氨基酸衍生物
CN1518558A (zh) 肽和/或蛋白质及其用于制备治疗性和/或预防性药物组合物的用途
CN1181092C (zh) 可用于治疗前列腺癌的缀合物
CN1777439A (zh) 生长抑素的载体
CN1054857C (zh) 具有胃肠道运动刺激活性的胃动素样多肽

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication